SCHEMBL8167199

SCHEMBL8167199

Nc1cccnc1N1CCN(C(=O)Cc2ccc(O)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ME2 P23368 5/20 0.54
ME1 P48163 5/20 0.54
ME3 Q16798 5/20 0.54
KDM4E B2RXH2 4/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HPGD P15428 2/20 0.48
HSD17B10 Q99714 2/20 0.48
RBP4 P02753 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH1A1 P00352 4/20 0.44
GAA P10253 1/20 0.44
ALOX12 P18054 1/20 0.44
HTT P42858 1/20 0.44
MAPT P10636 1/20 0.44
GFER P55789 1/20 0.44
ATM Q13315 1/20 0.44
POLB P06746 1/20 0.44
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8168851 0.86 SLC6A7 (0.53) ME2ME1ME3KDM4ESMN1; SMN2
SCHEMBL8163504 0.84 PANK3 (0.48) KDM4ESMN1; SMN2HPGDHSD17B10RBP4
SCHEMBL3329378 0.82 KDM4E (0.63) ME2ME1ME3KDM4ESMN1; SMN2
SCHEMBL8168338 0.82 SLC6A7 (0.55) ME2ME1ME3KDM4ESMN1; SMN2
SCHEMBL8172191 0.81 KDM4E (0.45) KDM4ESMN1; SMN2HPGDHSD17B10RBP4
SCHEMBL8168565 0.78 HPGD (0.45) KDM4ESMN1; SMN2HPGDHSD17B10RBP4
SCHEMBL3333923 0.77 KDM4E (0.62) KDM4ESMN1; SMN2RBP4ALDH1A1MAPT
SCHEMBL8921825 0.75 HDAC1 (0.58) SMN1; SMN2NPSR1
SCHEMBL23244396 0.74 ME2 (0.86) ME2ME1ME3KDM4EL3MBTL1
SCHEMBL12459920 0.72 KDM4E (0.77) ME2ME1ME3KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008112440-A1 PIPERAZINE AND PIPERIDINE MGLUR5 POTENTIATORS ASTRAZENECA AB (SE) 2008-09-18 WO disclosed